Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

CLARK ESTATES INC/NY 13F Holdings -- Portfolio & Top Positions (2026-06-30)

CLARK ESTATES INC/NY (CIK 1056466) reported $433.7M across 90 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: ECML ($66.7M, 15.37%), VEA ($26.4M, 6.10%), UL ($22.2M, 5.13%), DIS ($19.2M, 4.44%), AMRZ ($17.3M, 3.99%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1ECMLEA SERIES TRUST$66.7M15.37%1.7MTrimmed
2VEAVANGUARD TAX-MANAGED FDS$26.4M6.10%371,060New
3ULUNILEVER PLC$22.2M5.13%370,000Added
4DISDISNEY WALT CO$19.2M4.44%200,000Hold
5AMRZAMRIZE LTD$17.3M3.99%325,000Added
6SONYSONY GROUP CORP$16.5M3.82%825,000Added
7HLNHALEON PLC$15.9M3.66%1.7MAdded
8SOLVSOLVENTUM CORP$15.4M3.56%200,000Trimmed
9BLCOBAUSCH PLUS LOMB CORP$14.6M3.36%881,000Added
10WMGWARNER MUSIC GROUP CORP$14.5M3.34%535,000Trimmed
11HSICSCHEIN HENRY INC$11.3M2.60%135,000Added
12IQVIQVIA HLDGS INC$10.1M2.32%52,185Trimmed
13STTKSHATTUCK LABS INC$9.9M2.29%1.4MTrimmed
14MDTMEDTRONIC PLC$7.0M1.62%90,000Trimmed
15WLYWILEY JOHN & SONS INC$4.6M1.06%94,400Added
16DDD3D SYS CORP DEL$4.3M0.99%1.4MHold
17SNNSMITH & NEPHEW PLC$4.1M0.95%143,500Trimmed
18MDPEDIATRIX MEDICAL GROUP INC$3.9M0.89%153,000Added
19INDVINDIVIOR PHARMACEUTICALS INC$3.8M0.87%92,300Hold
20CPRXCATALYST PHARMACEUTICALS INC$3.6M0.83%113,918Hold
21HALOHALOZYME THERAPEUTICS INC$3.5M0.81%44,868Hold
22MOALTRIA GROUP INC$3.5M0.81%48,613Hold
23CROXCROCS INC$3.5M0.80%28,900Hold
24BBYBEST BUY INC$3.3M0.76%43,700New
25GILDGILEAD SCIENCES INC$3.3M0.76%26,022Hold

Source: SEC Form 13F filings · as of 2026-06-30